|
|
10665 Sorrento Valley Rd.
San Diego, CA 92121 USA
phone:858-452-2631
fax:
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.nexbio.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutics for the prevention and treatment of human respiratory diseases. |
|
| Management |
| Mang Yu, Ph.D., President & Chief Executive Officer (CEO); Fang Fang, M.D., Ph.D., Chief Scientific Officer (CSO) & Chief Medical
Officer (CMO); Ronald B. Moss, Executive Vice President of Clinical Development & Medical Affairs; Cal Bowman, VP, Product Development & Regulatory Affairs; David Wurtman, VP, Corporate Development; Dongmei Wang, Assistant Vice President, Finance and Administration |
| |
|
|
| |
|
| Keywords |
| prophylaxes, therapeutics, respiratory, infectious diseases, InfectiousDisease |
|
|
|
| Description |
|
NexBio Inc. develops novel, broad-spectrum prophylaxes and therapeutics for the prevention and treatment of human respiratory infectious diseases. |
|
| Products / Services |
NexBio currently has three R&D programs focusing on influenza and other key respiratory viruses: Fludase, Inviridin, and Viracidin.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members